Pure Global

Efficacy of Virtual Reality (VR) for Irritable Bowel Syndrome - Trial NCT06257472

Access comprehensive clinical trial information for NCT06257472 through Pure Global AI's free database. This phase not specified trial is sponsored by Anthony Lembo and is currently Recruiting. The study focuses on IBS - Irritable Bowel Syndrome. Target enrollment is 75 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06257472
Recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov • NCT06257472
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Efficacy of Virtual Reality (VR) for Irritable Bowel Syndrome
Efficacy of Virtual Reality (VR) for Irritable Bowel Syndrome: A Randomized Trial Comparing Brain-Gut Directed VR vs. Sham VR

Study Focus

Virtual Reality Headset

Interventional

device

Sponsor & Location

Anthony Lembo

The Cleveland Clinic

Los Angeles,Cleveland, United States of America

Timeline & Enrollment

N/A

Jun 01, 2024

Feb 01, 2025

75 participants

Primary Outcome

IBS-targeted HRQOL (health-related quality of life)

Summary

In this study, the investigators conduct a remote, eight-week, two-arm, randomized controlled
 trial that assesses the benefits, primarily measured through the irritable bowel syndrome
 (IBS)-targeted HRQOL (health-related quality of life), of an immersive, disease-targeted
 virtual reality program compared to a non-immersive virtual reality program for patients with
 IBS.

ICD-10 Classifications

Irritable bowel syndrome with predominant constipation [IBS-C]
Irritable bowel syndrome
Irritable bowel syndrome with predominant diarrhoea [IBS-D]
Irritable bowel syndrome with mixed bowel habits [IBS-M]
Other and unspecified irritable bowel syndrome

Data Source

ClinicalTrials.gov

NCT06257472

Device Trial